IP Library › Granted Patent US 10,655,131
Granted Patent B2
US 10,655,131 · App. 16/148,236 · Granted May 19, 2020

Aptamer specifically binding to L-Ascorbic acid and use of the same

Inventor: In-sik Son (Seongnam-si, KR)
Assignee: NEXMOX Co., Ltd.
C12N15/115C12N2310/16C12N2310/334C12N2310/336C12N2310/531
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,655,131
App. No.
16/148,236
Granted
May 19, 2020
Kind
B2
Abstract

The present invention relates to a single-stranded DNA aptamer which inhibits oxidation by binding to L-ascorbic acid, characterized in that the single stranded DNA aptamer has at least one of stem-loop structure, has CG bond at the end of the stem-loop structure, and both of the beginning parts of the stem-loop structure are G or C, in which the same bases are faced to each other. The aptamer of the present invention has an anti-oxidative effect of vitamin C, it can be used for functional cosmetics of various formulations, oral nutritional supplements, foods, etc. by maintaining the reduced state of vitamin C using the aptamer which selectively binds to vitamin C to maintain the anti-oxidative function of vitamin C for a long time. In addition, it can be anticipated that the anti-oxidative effect is continued and maximized even with a small amount of vitamin C by using the aptamer selectively binding to vitamin C.

Claims (7)

1. A single-stranded DNA aptamer which inhibits oxidation by binding to L-ascorbic acid,

the single stranded DNA aptamer having at least one

from 5′ to 3′ end direction CG-N1-XG step-loop structure,

wherein C is prior to an unpaired loop sequence G-N1-X in which N1 is any of 1 to 3 nucleotides and X is G or T, and G is subsequent to the unpaired loop sequence and forms a C-G bond with the C.

2. The single-stranded DNA aptamer of claim 1 , the DNA aptamer comprises a nucleotide sequence selected from the group consisting of SEQ ID NOS: 1, 4, 5, 17, 22, 23 and 26.

3. An anti-oxidative composition comprising the aptamer of claim 1 as an active ingredient.

4. A method for inhibiting oxidation of vitamin C by treating the vitamin C with the aptamer of claim 1 .

Priority Claims (2)
KR 10-2016-0026437 · Mar 4, 2016 · national
KR 10-2018-0102964 · Aug 30, 2018 · national
Continuity (3)
Continuation In Part 15654470 · Jul 19, 2017
Continuation In Part PCTKR2017002207 · Feb 28, 2017
Related Publication 20190078094A1 · Mar 14, 2019
Cited By (1)
US 12,227,747